Main Session
Oct
01
SS 45 - GU 10: Biomarker Breakthroughs in Prostate Cancer
357 - Testosterone Recovery post Androgen Depletion Therapy in Intermediate Risk Prostate Cancer Patients. Does a Higher Dose of Radiotherapy Impact on Survival? Long-Term Data from a Phase III Trial
Presenter(s)

Abdenour Nabid, MD - CHUS, Sherbrooke, QC